Quantcast

Tag Archives: pharmathene

NIH picks PharmAthene for vaccine

PharmAthene Inc., an Annapolis-based biodefense company, has been awarded a federal contract to develop an anthrax vaccine, worth a possible $28.1 million, the company announced this week. The contract came from the National Institute of Allergy and Infectious Diseases, part ...

Read More »

PharmAthene results match other vaccine

PharmAthene Inc., an Annapolis-based company that develops biodefense products, reported that its SparVax anthrax vaccine performed as well as the currently licensed anthrax vaccine, BioThrax, in a trial using rabbits. SparVax “provided equivalent protection against lethal aerosol anthrax challenge at ...

Read More »

PharmAthene forms partnership

PharmAthene Inc., an Annapolis-based company that develops biodefense products, announced it has formed a strategic alliance with Nanotherapeutics Inc., a biopharmaceutical company from Alachua, Florida. Under their alliance agreement, each company will contribute expertise and resources with the objective of ...

Read More »

On the Move, 8/8: Poulos named president of regional chapter of Sales and Marketing Executive International

David G. Poulos, CEO of Granite Partners, has been named president of the Baltimore/Washington chapter of Sales and Marketing Executives International. Poulos founded Sparks-based Granite Partners in 2006, after serving as director of marketing communications for Graphic Arts Show Co., ...

Read More »